Latest News
Marked Heterogeneity in the Diagnosis of Compensated Cirrhosis in Chronic HCV
Markers of HBeAg-Seroclearance in HIV-Hepatitis B Coinfection
Efficacy of Three Recommended Regimens for the Treatment of Hepatitis C Virus Genotype 3
Detecting and Predicting Progression of Subclinical Vascular Damage in PLWHIV
Meningococcal B Vaccine Does Not Affect Carriage
Coagulation Disorders and Bleeding Risks With Cefoperazone-Sulbactam
CDC Outlines US Process of Evaluating Patients for 2019-nCoV
Bronchiectasis Progression in COPD Associated With Preventable Risk Factors
Double-Dose Influenza Vaccine Doses May Not Benefit Pregnant Women With HIV
How Effective Is the WHO Recommended Antibiotic Regimen for Leprosy?
Ebola Virus RNA May Persist in Semen, Breast Milk for Longer Than Anticipated
Latent TB Infection Treatment: 4 Months of Rifampin vs 9 Months of Isoniazid
Antibiotics Are Unlikely Major Contributors to Childhood Obesity
Latest Features & Opinion
Cocaine Use and Hepatitis C Infection: What’s the Link?
Although the World Health Organization (WHO) has set a goal to significantly reduce HCV-related morbidity and mortality rates by 2030, HCV continues to pose a major public health threat.
How I Treat HIV-1 Infection With Emtricitabine and Tenofovir Alafenamide
Indira Brar, MD, discusses the use of emtricitabine/tenofovir alafenamide in adult patients with HIV-1 infection.
CDC Issues Updated Health Advisory for Novel Coronavirus Outbreak
The Centers for Disease Control and Prevention has issued an official health update for the outbreak of novel coronavirus 2019-nCoV.
Mental and Cognitive Impairment in Hepatitis C Virus
In the United States, approximately 3.5 million people are infected with the hepatitis C virus, which contributes to psychological and cognitive disorders for about half of all patients.
